 Macrophages, Alveolar
"Macrophages, Alveolar" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Round, granular, mononuclear phagocytes found in the alveoli of the lungs. They ingest small inhaled particles resulting in degradation and presentation of the antigen to immunocompetent cells.
| Descriptor ID |
D016676
|
| MeSH Number(s) |
A11.329.372.600 A11.627.482.600 A11.733.397.600 A15.382.680.397.600 A15.382.812.522.600
|
| Concept/Terms |
Macrophages, Alveolar- Macrophages, Alveolar
- Pulmonary Macrophages
- Pulmonary Macrophage
- Macrophages, Pulmonary
- Alveolar Macrophages
- Alveolar Macrophage
- Macrophage, Alveolar
- Macrophage, Pulmonary
|
Below are MeSH descriptors whose meaning is more general than "Macrophages, Alveolar".
Below are MeSH descriptors whose meaning is more specific than "Macrophages, Alveolar".
This graph shows the total number of publications written about "Macrophages, Alveolar" by people in this website by year, and whether "Macrophages, Alveolar" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1996 | 0 | 1 | 1 | | 1997 | 2 | 0 | 2 | | 1998 | 1 | 3 | 4 | | 1999 | 0 | 2 | 2 | | 2000 | 1 | 1 | 2 | | 2002 | 2 | 8 | 10 | | 2003 | 1 | 2 | 3 | | 2004 | 5 | 1 | 6 | | 2005 | 2 | 1 | 3 | | 2006 | 3 | 2 | 5 | | 2007 | 3 | 2 | 5 | | 2008 | 5 | 2 | 7 | | 2009 | 4 | 3 | 7 | | 2010 | 4 | 4 | 8 | | 2011 | 7 | 0 | 7 | | 2012 | 4 | 5 | 9 | | 2013 | 5 | 5 | 10 | | 2014 | 5 | 3 | 8 | | 2015 | 6 | 3 | 9 | | 2016 | 6 | 4 | 10 | | 2017 | 7 | 7 | 14 | | 2018 | 7 | 2 | 9 | | 2019 | 8 | 0 | 8 | | 2020 | 7 | 2 | 9 | | 2021 | 3 | 2 | 5 | | 2022 | 2 | 2 | 4 | | 2023 | 2 | 4 | 6 | | 2024 | 2 | 4 | 6 | | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Macrophages, Alveolar" by people in Profiles.
-
Little I, Bersie S, Redente EF, McCubbrey AL, Tarling EJ. Alveolar macrophages: guardians of the alveolar lipid galaxy. Curr Opin Lipidol. 2025 Jun 01; 36(3):153-162.
-
King EM, Zhao Y, Moore CM, Steinhart B, Anderson KC, Vestal B, Moore PK, McManus SA, Evans CM, Mould KJ, Redente EF, McCubbrey AL, Janssen WJ. Gpnmb and Spp1 mark a conserved macrophage injury response masking fibrosis-specific programming in the lung. JCI Insight. 2024 Dec 20; 9(24).
-
Chakraborty S, Cheng BY, Edwards DL, Gonzalez JC, Chiu DK, Zheng H, Scallan C, Guo X, Tan GS, Coffey GP, Conley PB, Hume PS, Janssen WJ, Byers DE, Mudd PA, Taubenberger J, Memoli M, Davis MM, Chua KF, Diamond MS, Andreakos E, Khatri P, Wang TT. Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease. Immunity. 2025 Jan 14; 58(1):182-196.e10.
-
Lewis CV, Garcia AM, Burciaga SD, Posey JN, Jordan M, Nguyen TN, Stenmark KR, Mickael C, Sul C, Delaney C, Nozik ES. Redistribution of SOD3 expression due to R213G polymorphism affects pulmonary interstitial macrophage reprogramming in response to hypoxia. Physiol Genomics. 2024 Nov 01; 56(11):776-790.
-
Kumar S, Mickael C, Kumar R, Prasad RR, Campbell NV, Zhang H, Li M, McKeon BA, Allen TE, Graham BB, Yu YA, Stenmark KR. Single cell transcriptomic analyses reveal diverse and dynamic changes of distinct populations of lung interstitial macrophages in hypoxia-induced pulmonary hypertension. Front Immunol. 2024; 15:1372959.
-
Pennington ER, Virk R, Bridges MD, Bathon BE, Beatty N, Gray RS, Kelley P, Wassall SR, Manke J, Armstrong M, Reisdorph N, Vanduinen R, Fenton JI, Gowdy KM, Shaikh SR. Docosahexaenoic Acid Controls Pulmonary Macrophage Lipid Raft Size and Inflammation. J Nutr. 2024 06; 154(6):1945-1958.
-
Lee E, Williams KJ, McCarthy C, Bridges JP, Redente EF, de Aguiar Vallim TQ, Barrington RA, Wang T, Tarling EJ. Alveolar macrophage lipid burden correlates with clinical improvement in patients with pulmonary alveolar proteinosis. J Lipid Res. 2024 02; 65(2):100496.
-
Neehus AL, Carey B, Landekic M, Panikulam P, Deutsch G, Ogishi M, Arango-Franco CA, Philippot Q, Modaresi M, Mohammadzadeh I, Corcini Berndt M, Rinchai D, Le Voyer T, Rosain J, Momenilandi M, Martin-Fernandez M, Khan T, Bohlen J, Han JE, Deslys A, Bernard M, Gajardo-Carrasco T, Soud?e C, Le Floc'h C, Migaud M, Seeleuthner Y, Jang MS, Nikolouli E, Seyedpour S, Begueret H, Emile JF, Le Guen P, Tavazzi G, Colombo CNJ, Marzani FC, Angelini M, Trespidi F, Ghirardello S, Alipour N, Molitor A, Carapito R, Mazloomrezaei M, Rokni-Zadeh H, Changi-Ashtiani M, Brouzes C, Vargas P, Borghesi A, Lachmann N, Bahram S, Crestani B, Fayon M, Galode F, Pahari S, Schlesinger LS, Marr N, Bogunovic D, Boisson-Dupuis S, B?ziat V, Abel L, Borie R, Young LR, Deterding R, Shahrooei M, Rezaei N, Parvaneh N, Craven D, Gros P, Malo D, Sepulveda FE, Nogee LM, Aladjidi N, Trapnell BC, Casanova JL, Bustamante J. Human inherited CCR2 deficiency underlies progressive polycystic lung disease. Cell. 2024 01 18; 187(2):390-408.e23.
-
Hall TJ, McHugo GP, Mullen MP, Ward JA, Killick KE, Browne JA, Gordon SV, MacHugh DE. Integrative and comparative genomic analyses of mammalian macrophage responses to intracellular mycobacterial pathogens. Tuberculosis (Edinb). 2024 Jul; 147:102453.
-
Roy RM, Allawzi A, Burns N, Sul C, Rubio V, Graham J, Stenmark K, Nozik ES, Tuder RM, Vohwinkel CU. Lactate produced by alveolar type II cells suppresses inflammatory alveolar macrophages in acute lung injury. FASEB J. 2023 12; 37(12):e23316.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|